Physician profile
Kendra Winter
NPI 1710474424
$1,703.65
in general payments reported to CMS, 2019-2025
18 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $97.07 · 2023: $610 · 2024: $496 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397 · Education: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,396.58 |
| Education | $210.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leica Microsystems INC. | $400.00 | 2023 | |
| Elucent Medical | $269.78 | 2025 | |
| Molli Surgical (US) INC | $155.76 | 2024 | |
| Daiichi Sankyo INC. | $154.43 | 2024-2025 | Enhertu |
| Astrazeneca Pharmaceuticals Lp | $140.73 | 2024 | Enhertu, Imfinzi |
| Lemaitre Vascular, INC. | $122.56 | 2023 | Hydro Lemaitre Valvulotome |
| Boston Scientific Corporation | $97.07 | 2022 | |
| Lilly USA, LLC | $77.21 | 2024 | Verzenio, Retevmo, Jaypirca |
| Endomagnetics Ltd | $59.47 | 2023 | Magseed, Magtrace |
| Merck Sharp & Dohme LLC | $43.91 | 2025 | Keytruda, Lynparza |
| Davol INC. | $32.46 | 2025 | Arista |
| Janssen Pharmaceuticals, INC | $32.07 | 2024 | Xarelto |
| Axogen | $29.15 | 2025 | |
| Eisai INC. | $24.12 | 2024 | |
| Genmab U.S., INC. | $20.58 | 2024 | Tivdak |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.31 | 2024 | |
| Monaghan Medical Corporation | $14.37 | 2023 | Aeroeclipse |
| Seagen INC. | $13.67 | 2023 | Tukysa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.